1. Generics Bulletin

Celltrion Eyes Direct Global Sales To Bolster Margins, Growth

 
• By Jung Won Shin

Biosimilar specialist Celltrion is aiming for the next stage of growth by setting up its own global direct sales and marketing system and through a new subcutaneous formulation of infliximab, and is looking to begin discussions with existing overseas marketing partners.

Celltrion briefing
Celltrion chairman Jung Jin Seo speaks at a briefing in Seoul • Source: Celltrion Inc.

Celltrion Group is seeking further growth and an improvement in profit margins through the setting up of its own direct global sales, marketing and distribution system for new products, and for its already commercialized lines if it is unable to find "win-win" strategies with existing partners for these.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Biosimilars

More from Products